LeMaitre Vascular Inc (LMAT)
LeMaitre Vascular, Inc. is a healthcare company focused on medical devices and implants used in vascular surgery. Its product range includes allografts, embolectomy and thrombectomy catheters, occlusion and perfusion catheters, biologic grafts and patches, carotid shunts, biosynthetic and expanded polytetrafluoroethylene vascular grafts, phlebectomy systems, valvulotomes, radiopaque tape, and closure systems used to connect vessels with titanium clips. The company also provides human cadaver tissue cryopreservation services. LeMaitre Vascular sells its products in the Americas, Europe, the Middle East, Africa, and Asia Pacific through a direct sales force and distributors. Incorporated in 1983 and headquartered in Burlington, Massachusetts, the company was formerly known as Vascutech, Inc. before adopting its current name in April 2001.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-LMAT
|
$87.83
|
-13.1% Downside
|
Fair
|
$118.75
|
17.4% Upside
|
Fair
|
Great
|
—
|
—
|
1
|
1.0%
|
August 4, 2026
|
37.0x
|
5.7x
|
9.0x
|
2.324 B
|
2.132 B
|
7.6%
|
93.1%
|
8.7
|
30.9%
|
126.8%
|
